Publications by authors named "Miguel Angel Carvajal-Sanchez"
What Is Known And Objective: Erenumab is a monoclonal antibody for the prophylactic treatment of migraine. We describe the first cases of xerostomia probably induced by this drug.
Case Summary: We present two patients diagnosed with chronic migraine who started treatment with erenumab and presented with dry mouth after the first and second dose.